Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2025-12-26 @ 3:13 AM
Study NCT ID:
NCT04128020
Status:
WITHDRAWN
Last Update Posted:
2020-10-12
First Post:
2019-10-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Azacitidine Plus Nivolumab Following Reduced-intensity Allogeneic PBSC Transplantation for Patients With AML and High-risk Myelodysplasia
Sponsor:
Sherif Farag
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-10
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-28
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-14
First Submit QC Date:
None
Study First Post Date:
2019-10-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-09
Last Update Post Date:
2020-10-12
Last Update Post Date Type:
ACTUAL